Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection

被引:10
作者
Lunz, Andre [1 ]
Omlor, Georg W. [1 ]
Schmidt, Gunter [1 ]
Moradi, Babak [2 ]
Lehner, Burkhard [1 ]
Streit, Marcus R. [3 ]
机构
[1] Heidelberg Univ Hosp, Clin Orthoped & Trauma Surg, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Schlierbacher Landstr 200a, D-69118 Heidelberg, Germany
[2] Univ Med Ctr Schleswig Holstein, Clin Orthoped & Traumatol, Campus Kiel, Kiel, Germany
[3] ARCUS Sportklin, Pforzheim, Germany
关键词
Two-stage revision; Periprosthetic joint infection; Antibiotic-loaded cement spacer; Articulating spacer; Metal-on-cement; Quality of life; CEMENT SPACERS; KNEE ARTHROPLASTY; SINGLE-STAGE; ASSOCIATION; ASPIRATION; EXCHANGE;
D O I
10.1007/s00402-021-04274-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Introduction Two-stage revision remains the gold standard treatment for most chronically infected and complex total hip arthroplasty infections. To improve patient outcome and reduce complication rates, we have developed a novel custom-made articulating hip spacer technique and present our short-term results. Materials and methods Between November 2017 and November 2019, 27 patients (mean age 70 years) underwent two-stage revision for periprosthetic joint infection of the hip using the articulating spacer design described here. We retrospectively analyzed spacer-related complications as well as rates for complication, infection control, and implant survivorship after final reimplantation. Furthermore, we prospectively collected patient-reported health-related quality of life (HRQoL) scores prior to spacer implantation, with the spacer and after reimplantation of the new prosthesis. Results An additional round of spacer exchange was performed in two patients (8.3%), persistent wound discharge was the reason in both cases. We had one (4.2%) spacer-related mechanical complication, a dislocation that was treated with closed reduction. After reimplantation, infection control was achieved in 96% with an implant survivorship of 92% after a mean follow-up time of 19 (range 7-32, SD 7.2) months. While the scores for VR-12 MCS, VAS hip pain and patient-reported overall satisfaction significantly improved after first stage surgery, the scores for WOMAC, UCLA and VR-12 PCS significantly improved after second stage surgery. Conclusions Our two-stage approach for periprosthetic joint infection shows high infection eradication and implant survivorship rates at short-term follow-up. Spacer-related complication rates were low, and we achieved high patient satisfaction rates and low pain levels already during the spacer period. To further simplify comparison between different spacer designs, we propose a new hip spacer classification system.
引用
收藏
页码:4041 / 4054
页数:14
相关论文
共 44 条
[1]   Hip and Knee Section, Treatment, Two-Stage Exchange Spacer-Related: Proceedings of International Consensus on Orthopedic Infections [J].
Abdel, Matthew P. ;
Barreira, Pedro ;
Battenberg, Andrew ;
Berry, Daniel J. ;
Blevins, Kier ;
Font-Vizcarra, Lluis ;
Frommelt, Lars ;
Goswami, Karan ;
Greiner, Justin ;
Janz, Viktor ;
Kendoff, D. O. ;
Limberg, A. K. ;
Manrique, Jorge ;
Moretti, Biagio ;
Murylev, Valeriy ;
O'Byrne, John ;
Petrie, Michael J. ;
Porteous, Andrew ;
Saleri, Solmaz ;
Sandiford, Nemandra A. ;
Sharma, Vishwas ;
Shubnyakov, Igor ;
Sporer, Scott ;
Squire, Matthew W. ;
Stockley, Ian ;
Tibbo, M. E. ;
Turgeon, Thomas ;
Varshneya, Ankit ;
Wellman, Samuel ;
Zahar, Akos .
JOURNAL OF ARTHROPLASTY, 2019, 34 (02) :S427-S438
[2]   Antibiotic-loaded cement spacers - lessons learned from the past 20 years [J].
Anagnostakos, Konstantinos ;
Fink, Bernd .
EXPERT REVIEW OF MEDICAL DEVICES, 2018, 15 (03) :231-245
[3]  
Becker A, 2020, J Bone Jt Infect, V5, P28, DOI 10.7150/jbji.40333
[4]  
Bellamy N., 1833, J RHEUMATOL, V15, P1988
[5]   Two-Stage Revision Total Hip Arthroplasty With a Specific Articulating Antibiotic Spacer Design: Reliable Periprosthetic Joint Infection Eradication and Functional Improvement [J].
Chalmers, Brian P. ;
Mabry, Tad M. ;
Abdel, Matthew P. ;
Berry, Daniel J. ;
Hanssen, Arlen D. ;
Perry, Kevin I. .
JOURNAL OF ARTHROPLASTY, 2018, 33 (12) :3746-3753
[6]   Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection [J].
Charette R.S. ;
Melnic C.M. .
Current Reviews in Musculoskeletal Medicine, 2018, 11 (3) :332-340
[7]   Increasing risk of prosthetic joint infection after total hip arthroplasty 2,778 revisions due to infection after 432,168 primary THAs in the Nordic Arthroplasty Register Association (NARA) [J].
Dale, Havard ;
Fenstad, Anne M. ;
Hallan, Geir ;
Havelin, Leif I. ;
Furnes, Ove ;
Overgaard, Soren ;
Pedersen, Alma B. ;
Karrholm, Johan ;
Garellick, Goran ;
Pulkkinen, Pekka ;
Eskelinen, Antti ;
Makela, Keijo ;
Engesaeter, Lars B. .
ACTA ORTHOPAEDICA, 2012, 83 (05) :449-458
[8]   Success After Treatment of Periprosthetic Joint Infection: A Delphi-based International Multidisciplinary Consensus [J].
Diaz-Ledezma, Claudio ;
Higuera, Carlos A. ;
Parvizi, Javad .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2013, 471 (07) :2374-2382
[9]   A Low Percentage of Patients Satisfy Typical Indications for Single-stage Exchange Arthroplasty for Chronic Periprosthetic Joint Infection [J].
Dombrowski, M. E. ;
Wilson, A. E. ;
Wawrose, R. A. ;
O'Malley, M. J. ;
Urish, K. L. ;
Klatt, B. A. .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2020, 478 (08) :1780-1786
[10]   Spacer endoprosthesis for the treatment of infected total hip arthroplasty [J].
Durbhakula, SM ;
Czajka, J ;
Fuchs, MD ;
Uhl, RL .
JOURNAL OF ARTHROPLASTY, 2004, 19 (06) :760-767